COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2
COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of High Doses CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU
Sponsor: Bellco Srl Mirandola, Italy
Listed as NCT01639664, this NA trial focuses on Shock, Septic and remains terminated or withdrawn. Sponsored by Bellco Srl Mirandola, Italy, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Feb 2025 — Sep 2025 [monthly]
Terminated NA
-
Sep 2024 — Feb 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
-
Oct 2021 — Dec 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated · Phase: PHASE4 → NA
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE4
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bellco Srl Mirandola, Italy
- Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Cesena, Italy , Chieri, Italy , Florence, Italy , Forlì, Italy , Lecco, Italy , Matera, Italy , Moncalieri, Italy , Montepulciano, Italy , Pescia, Italy and 2 more locations